Skip Navigation LinksHome > News & Events > Past Events > Past Event

Applications of CRISPR Technologies in Research and Industry

3/30/2017, 6:30 PM to 8:30 PM | German House New York

Applications of CRISPR Technologies in Research and Industry

Co-Sponsors:
• New Jersey Innovation Institute
• University of Cologne

Few discoveries have attracted more attention in the area of molecular biology over the last three years than CRISPR-Cas9, a relatively new technology that is groundbreaking, controversial and developing rapidly. Science Magazine featured CRISPR-Cas9 on its cover in 2015, calling it a "breakthrough," and MIT Technology Review called it the "biggest biotech discovery of the century." The technology makes gene editing simple, affordable, and precise. At present, scientists are exploring the potential of CRISPR-Cas9 to cure a host of human diseases. These tools are also being used to expedite crop and livestock breeding, engineer new antimicrobials and control disease-carrying insects.

Our panelists addressed a number of the applications of this cutting-edge technology and discussed some of its challenges.

View Gallery

View Video

  • Featured Speakers

    • Dr. Paul Bernasconi

      Director, Molecular Biology; Manager, RTP Plant Science Research Site, BASF

    • Prof. Dr. Branko Zevnik

      Head, in vivo Research Facility, CECAD Cologne

    • Dr. Ghassan Yehia

      Scientific Director, Genome Editing Core Facility, Rutgers, the State University of New Jersey

    • Dr. Benedikt Bosbach (Moderator)

      Researcher, Oncology Target Discovery Program, Pfizer